DEF 14A: N2OFF, Inc. Seeks Stockholder Approval for Director Elections, Share Incentive Plan Amendment, and Potential Equity Issuance

N2OFF, Inc. is holding its annual meeting of stockholders on November 13, 2024, to vote on key proposals including the election of directors, an amendment to the share incentive plan, an increase in authorized capital, and the potential issuance of securities in non-public offerings.

Summary

• N2OFF, Inc. is convening its annual meeting of stockholders on November 13, 2024, to address several key proposals.
• The proposals include the election of two Class III directors (Eliahou Arbib and Udi Kalifi) for a three-year term.
• Stockholders will also vote on an amendment to the 2022 Share Incentive Plan to increase the number of shares available for issuance.
• A significant proposal involves granting the board discretionary authority to amend the Articles of Incorporation to increase the number of authorized shares of capital stock from 500,000,000 to 10,005,000,000.
• An advisory vote will be held to approve a grant of shares to board members under the 2022 Plan.
• The ratification of Somekh Chaikin, a member of KPMG International, as the company's independent auditors for the fiscal year ending December 31, 2024, is also on the agenda.
• Finally, stockholders will vote on approving the issuance of securities in one or more non-public offerings, with a maximum discount of 20% below the market price, as required by Nasdaq rules.
• The board of directors recommends voting FOR all proposals.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily focused on outlining the proposals for the annual meeting. The potential for dilution from equity issuances is a concern, but the company is also seeking to incentivize employees and directors and raise capital for future growth.

Positives

• The board is actively seeking stockholder input on key governance and compensation matters.
• The proposed increase in authorized shares could provide flexibility for future capital-raising activities and strategic opportunities.
• The company is addressing the need to incentivize and retain key employees and directors through the share incentive plan amendment.
• The board is recommending a vote FOR all proposals.

Negatives

• The potential issuance of securities in non-public offerings could dilute existing stockholders' ownership.
• Increasing the authorized share capital could have potential anti-takeover effects, although the company states this is not the intention.
• The company has sold a significant number of shares to YA II PN, Ltd. at a discount.

Risks

• Failure to approve the increase in authorized shares could limit the company's ability to raise capital and execute its business plan.
• The potential for dilution from future equity issuances could negatively impact existing stockholders.
• The company's reliance on the YA II PN, Ltd. purchase agreement for financing carries risks associated with market volatility and the investor's ability to purchase shares.
• The enforceability of non-competition provisions in executive officer consulting agreements may be limited under applicable law.

Future Outlook

The company is seeking flexibility to raise capital and implement its business strategy through potential equity issuances and an increase in authorized shares.

Industry Context

Many companies use equity-based compensation plans to attract and retain talent, and the proposed amendment to the 2022 Plan aligns with this industry practice. The potential equity issuance is a common method for companies to raise capital, but the terms and conditions can vary significantly depending on market conditions and the company's specific needs.

Comparison to Industry Standards

• The use of equity compensation plans is a standard practice among publicly traded companies to align the interests of employees and directors with those of shareholders.
• Companies like Jeffs Brands Ltd. (Nasdaq: JFBR), Clearmind Medicine Inc. (Nasdaq: CMND), and SciSparc Ltd. (Nasdaq: SPRC) also have directors serving on N2OFF's board, indicating a network of individuals involved in multiple publicly traded entities, which is not uncommon.
• The proposed increase in authorized shares is a significant move, and its impact will depend on how the company utilizes these shares in the future.

Related Party Transactions

• On March 31, 2023, we entered into a securities exchange agreement with Plantify Foods, Inc., a Canadian company (Plantify), pursuant to which each of the parties agreed to issue to the other party 19.99% of its issued and outstanding capital stock.
• Asaf Itzhaik and Israel Berenstein currently serve as members of the board of directors of our company and Plantify.

Stakeholder Impact

• Stockholders will be impacted by the decisions made at the annual meeting, particularly regarding equity dilution and the company's ability to raise capital.
• Employees and directors will be affected by the amendment to the share incentive plan.
• The company's financial performance and strategic direction will be influenced by the outcome of these proposals.

Next Steps

• Stockholders need to review the proxy statement and vote on the proposals.
• The company will hold its annual meeting on November 13, 2024.
• The board will implement the approved proposals, including the potential equity issuance and amendment to the share incentive plan.

Key Dates

Keywords

annual meeting, proxy statement, directors, share incentive plan, authorized capital, equity issuance, auditor ratification, N2OFF, stockholders, governance